跳至主要内容
临床试验/NCT06142435
NCT06142435招募中不适用

Mild Traumatic Brain Injury Identification and Monitoring Through Retional Scanning

Rebiscan, Inc.2 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2023年8月15日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
招募中
入组人数
60
试验地点
2
主要终点
TBI Detection

研究概览

简要总结

Rebion has developed a device, the Rebion trauma tool (referred to as the head and intraocular trauma tool, or "HITT"), that detects ocular fixation and alignment using a binocular retinal scan. Preliminary data obtained from hospitalized patients with a clinically-confirmed traumatic brain injury (TBI) and uninjured controls indicates that the device can detect changes in ocular fixation, alignment, and saccades that are related to brain injury. This study seeks to evaluate the ability of the Rebion trauma tool to assess perturbations in eye movements resulting from TBI. The study will enroll 60 TBI patients and 20 controls.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 45 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • Age 18-45 years
  • Presents to the facility within 2 weeks of head trauma
  • Able to provide informed consent
  • If minor, then able to provide parental consent and minor consent
  • Able to participate in the examination, including the ability to follow simple instructions
  • Fluency in English or Spanish

排除标准

  • Glasgow Coma Scale score equal to or less than 13 at the time of study enrollment
  • Under the influence of alcohol or drugs
  • Previous eye surgery
  • Visual acuity known to be 20/200 or less in either eye
  • Known strabismus, amblyopia (lazy eye), or double vision
  • Known eye movement disorder, including nystagmus
  • Known optic nerve disease, including papilledema or optic neuropathy
  • Known retinal disease, including macular degeneration or retinal degeneration
  • Known cataract
  • History of neurosurgery
  • History of stroke/brain hemorrhage, brain tumor, or epilepsy
  • Any head trauma requiring medical attention from a physician within the last 6 months
  • Diagnosed dementia or cognitive impairment requiring assistance for daily living
  • Other condition(s) under the care of a neurologist
  • Psychiatric hospitalization in the last 90 days
  • Subject considered unsuitable for participation in this clinical trial by PI, treating clinician, or study research staff
  • Any minor brain injury regardless of loss of consciousness

研究组 & 干预措施

Controls

Participants should not be part of the Intended Use Population. Subjects that present to the hospital, clinic, or emergency department, either as a patient or non-patient, with no history of head trauma and, are 18-45 years of age.

干预措施: Head and Intraocular Trauma Tool (Device)

TBI-Suspected Patients

TBI participants 18-45 years of age, recruited from patients at a clinical research facility who present with head trauma. Clinical evaluation for the patient can be positive (target condition present) or negative (target condition absent) for mTBI. Testing will occur on Day-0, Day-14, and Day-30.

干预措施: Head and Intraocular Trauma Tool (Device)

结局指标

主要结局

TBI Detection

时间窗: 1 day

Patients who present with suspected TBI to the clinic will have their eyes scanned to identify whether the HITT device can accurately identify patients with TBI.

次要结局

  • TBI Monitor(30 days)
  • TBI Monitor(14 days)

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验